alexa Defibrotide for Prevention and Treatment of Veno-Occlusive Disease in Adults: Single-Center Experience

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Defibrotide for Prevention and Treatment of Veno-Occlusive Disease in Adults: Single-Center Experience

Hepatic veno-occlusive disease (VOD) -also known as sinusoidal obstruction syndrome- is considered one of the leading causes of morbidity and mortality after hematopoietic stem cell transplantation (HSCT). Pathophysiology is thought to be multifactorial: endothelial injury in both sinusoids and small hepatic venules leading to subendothelial deposition of platelet and coagulative material, which results in centrilobular necrosis and post-sinusoidal obstruction ]. Defibrotide is a mixture of porcine oligodeoxyribonucleotides that has antithrombotic, anti-ischemic and anti-inflammatory properties.

Citation: Ipek Y, Hakki KO, Sevgi KB, Deniz SF (2014) Defibrotide for Prevention and Treatment of Veno-Occlusive Disease in Adults: Single-Center Experience. J Bone Marrow Res 2:148.

 
  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger